SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 on a Randomized Phase II PACE (Palbociclib After CDK4/6i & ET) Study: Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-Treated ER+/HER2- mBC
By
SABCS 2022 Conference Coverage
FEATURING
Erica Mayer
By
SABCS 2022 Conference Coverage
FEATURING
Erica Mayer
316 views
December 13, 2022
Login to view comments.
Click here to Login
Videos